50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
German leader seeks energy deals, alliances on Gulf trip
One Stock Doubles Your Money, During Crisis? (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Poverty and inflation: Egypt's economy hit by global turmoil
Kim Kardashian culls Dolce&Gabbana archives for Milan show
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
German leader seeks energy deals, alliances on Gulf trip
One Stock Doubles Your Money, During Crisis? (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Poverty and inflation: Egypt's economy hit by global turmoil
Kim Kardashian culls Dolce&Gabbana archives for Milan show
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
German leader seeks energy deals, alliances on Gulf trip
One Stock Doubles Your Money, During Crisis? (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Poverty and inflation: Egypt's economy hit by global turmoil
Kim Kardashian culls Dolce&Gabbana archives for Milan show
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
German leader seeks energy deals, alliances on Gulf trip
One Stock Doubles Your Money, During Crisis? (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Poverty and inflation: Egypt's economy hit by global turmoil
Kim Kardashian culls Dolce&Gabbana archives for Milan show
NYSE:BAX

Baxter International - BAX Stock Forecast, Price & News

$55.41
+0.04 (+0.07%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$54.56
$55.58
50-Day Range
$54.66
$66.80
52-Week Range
$54.45
$89.70
Volume
2.61 million shs
Average Volume
2.91 million shs
Market Capitalization
$27.91 billion
P/E Ratio
27.71
Dividend Yield
2.10%
Price Target
$77.69

Baxter International MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
40.2% Upside
$77.69 Price Target
Short Interest
Healthy
1.01% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
0.52mentions of Baxter International in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
6.89%
From $3.63 to $3.88 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.82 out of 5 stars

Medical Sector

60th out of 1,075 stocks

Surgical & Medical Instruments Industry

6th out of 104 stocks

BAX stock logo

About Baxter International (NYSE:BAX) Stock

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Stock News Headlines

Baxter Weighs Sale of Two Kidney-Care Businesses
This Bargain Stock Should Offer Healthy Gains
BAX October 7th Options Begin Trading
See More Headlines
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Company Calendar

Ex-Dividend for 7/1 Dividend
6/02/2022
Dividend Payable
7/01/2022
Last Earnings
7/28/2022
Ex-Dividend for 10/3 Dividend
9/01/2022
Today
9/25/2022
Dividend Payable
10/03/2022
Next Earnings (Confirmed)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Forecast
$77.69
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+40.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
10 Analysts

Profitability

Net Income
$1.28 billion
Pretax Margin
7.91%

Debt

Sales & Book Value

Annual Sales
$12.78 billion
Cash Flow
$5.45 per share
Book Value
$18.22 per share

Miscellaneous

Free Float
502,553,000
Market Cap
$27.91 billion
Optionable
Optionable
Beta
0.60

Social Links


Key Executives

  • Mr. Jose E. Almeida (Age 60)
    Chairman, Pres & CEO
    Comp: $3.72M
  • Mr. James K. Saccaro (Age 49)
    Exec. VP & CFO
    Comp: $1.62M
  • Mr. Giuseppe  AccogliMr. Giuseppe Accogli (Age 51)
    Exec. VP & COO
    Comp: $1.78M
  • Mr. Cristiano Franzi (Age 59)
    Sr. VP & Pres for EMEA
    Comp: $1.76M
  • Mr. Brian C. StevensMr. Brian C. Stevens (Age 47)
    Sr. VP, Chief Accounting Officer & Controller
  • Mr. Talvis P. Love (Age 53)
    Sr. VP & Chief Information Officer
  • Ms. Clare Trachtman
    VP of Investor Relations
  • Mr. David S. Rosenbloom
    Sr. VP & Gen. Counsel
  • Ms. Stacey Eisen
    Sr. VP of Global Communications
  • Ms. Jeanne K. MasonMs. Jeanne K. Mason (Age 66)
    Sr. VP of HR













BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BAX shares.
View BAX analyst ratings
or view top-rated stocks.

What is Baxter International's stock price forecast for 2022?

10 equities research analysts have issued 12 month price objectives for Baxter International's shares. Their BAX share price forecasts range from $60.00 to $100.00. On average, they predict the company's stock price to reach $77.69 in the next year. This suggests a possible upside of 40.2% from the stock's current price.
View analysts price targets for BAX
or view top-rated stocks among Wall Street analysts.

How have BAX shares performed in 2022?

Baxter International's stock was trading at $85.84 on January 1st, 2022. Since then, BAX stock has decreased by 35.4% and is now trading at $55.41.
View the best growth stocks for 2022 here
.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 5,090,000 shares, an increase of 12.6% from the August 15th total of 4,520,000 shares. Based on an average daily volume of 3,180,000 shares, the days-to-cover ratio is currently 1.6 days. Currently, 1.0% of the company's shares are sold short.
View Baxter International's Short Interest
.

When is Baxter International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our BAX earnings forecast
.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, October 27th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) posted its earnings results on Thursday, July, 28th. The medical instruments supplier reported $0.87 earnings per share for the quarter, meeting the consensus estimate of $0.87. The medical instruments supplier earned $3.75 billion during the quarter, compared to the consensus estimate of $3.88 billion. Baxter International had a trailing twelve-month return on equity of 21.75% and a net margin of 7.12%. The business's quarterly revenue was up 20.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.80 earnings per share.
Read the conference call transcript
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, July 12th. Shareholders of record on Friday, September 2nd will be paid a dividend of $0.29 per share on Monday, October 3rd. This represents a $1.16 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Thursday, September 1st.
Read our dividend analysis for BAX
.

Is Baxter International a good dividend stock?

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.10%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 58.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BAX will have a dividend payout ratio of 29.90% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BAX.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $3.60-$3.70 for the period, compared to the consensus estimate of $4.13. The company issued revenue guidance of -.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include California Public Employees Retirement System (0.72%), Caisse DE Depot ET Placement DU Quebec (0.72%), UBS Asset Management Americas Inc. (0.43%), Amundi (0.40%), Sumitomo Mitsui Trust Holdings Inc. (0.30%) and Cooke & Bieler LP (0.26%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends
.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $55.41.

How much money does Baxter International make?

Baxter International (NYSE:BAX) has a market capitalization of $27.91 billion and generates $12.78 billion in revenue each year. The medical instruments supplier earns $1.28 billion in net income (profit) each year or $2.00 on an earnings per share basis.

How many employees does Baxter International have?

The company employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?
The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More
How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 9/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.